SEC Form 4 · accession 0001193125-26-341086
TEVA PHARMACEUTICAL INDUSTRIES LTD · TEVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tal Zvi Zaks
Director
Period of report
Aug 5, 2026
Accepted (ET)
Aug 10, 2026 · 6:07 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000818686
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Aug 5, 2026 | S | 17 | $34.8655 | D | 73,247 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.